Pharmacodynamics of tolfenamic acid in dogs. Evaluation of dose response relationships

Keyphrases

• 12-hydroxyeicosatetraenoic Acid 33%
• Acid Generation 16%
• Area under the Concentration-time Curve 16%
• AUC Value 16%
• Beagle Dog 16%
• Carrageenan 50%
• Cellular Accumulation 16%
• Clot 33%
• Dose Level 33%
• Dose Rate 33%
• Dose-response Relationship 100%
• Drug Administration 16%
• Inflammatory Exudate 33%
• Leukocytes 16%
• Linear Pharmacokinetics 16%
• Non-inflamed 16%
• Pharmacodynamics 100%
• Potent Inhibitor 33%
• Prostaglandin E2 50%
• Rate 1 16%
• Skin Temperature 33%
• Subcutaneous Tissue 16%
• Thromboxane B2 (TXB2) 33%
• Tissue Cage 50%
• Tolfenamic Acid 100%
• White Blood Cells 16%

Pharmacology, Toxicology and Pharmaceutical Science

• 12 Hydroxyicosatetraenoic Acid 33%
• Beagle 16%
• Carrageenan 50%
• Dose-Response Relationship 100%
• Drug Administration 16%
• Exudate 33%
• Pharmacodynamics 100%
• Pharmacokinetics 16%
• Prostaglandin E2 50%
• Thromboxane B2 33%
• Tolfenamic Acid 100%

Veterinary Science and Veterinary Medicine

• 12-Hydroxyeicosatetraenoic Acid 33%
• Dog 100%
• Exudate 33%
• Leukocyte 33%
• Prostaglandin E2 50%
• Subcutaneous Tissue 16%
• Thromboxane B2 33%
• Tolfenamic Acid 100%